Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study

SIMPLE SUMMARY: To investigate the organ-specific responses and clinical outcomes of mixed responses (MRs) to treatment with pembrolizumab for unresectable or metastatic urothelial carcinoma (ur/mUC), 136 patients were analyzed retrospectively. The total objective response rate (ORR) and organ-speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Takuto, Miyake, Makito, Nishimura, Nobutaka, Inoue, Kuniaki, Fujii, Koyo, Iemura, Yusuke, Ichikawa, Kazuki, Omori, Chihiro, Tomizawa, Mitsuru, Maesaka, Fumisato, Oda, Yuki, Miyamoto, Tatsuki, Sakamoto, Keiichi, Kiba, Keisuke, Tanaka, Masahiro, Oyama, Nobuo, Okajima, Eijiro, Fujimoto, Ken, Hori, Shunta, Morizawa, Yosuke, Gotoh, Daisuke, Nakai, Yasushi, Torimoto, Kazumasa, Tanaka, Nobumichi, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997142/
https://www.ncbi.nlm.nih.gov/pubmed/35406508
http://dx.doi.org/10.3390/cancers14071735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997142/
https://www.ncbi.nlm.nih.gov/pubmed/35406508
http://dx.doi.org/10.3390/cancers14071735

Ejemplares similares